Beachboard D C, Horner SM. 2016. Innate immune evasion strategies of DNA and RNA viruses. Current Opinion in Microbiology, 32, 113–119.

Best S M, Morris K L, Shannon J G, Robertson S J, Mitzel D N, Park G S, Boer E, Wolfinbarger J B, Bloom M E. 2005. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne Flavivirus and identification of NS5 as an interferon antagonist. Journal of Virology, 79, 12828–12839.

Brubaker S W, Bonham K S, Zanoni I, Kagan J C. 2015. Innate immune pattern recognition: a cell biological perspective. Annual Review of Immunology, 33, 257–290.

Conradie A M, Bertzbach L D, Bhandari N, Parcells M, Kaufer B B. 2019. A common live-attenuated avian herpesvirus vaccine expresses a very potent oncogene. mSphere, 4, e00658-19.

Darnell J E, Jr., Kerr I M, Stark G R. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science, 264, 1415–1421.

Davidson I. 2020. Out of sight, but not out of mind: aspects of the avian oncogenic herpesvirus, Marek’s disease virus. Animals (Basel), 10, 1319.

Fan T J, Han L H, Cong R S, Liang J. 2005. Caspase family proteases and apoptosis. Acta Biochimica et Biophysica Sinica, 37, 719–727.

Heidari M, Wang D, Delekta P, Sun S. 2016. Marek’s disease virus immunosuppression alters host cellular responses and immune gene expression in the skin of infected chickens. Veterinary Immunology and Immunopathology, 180, 21–28.

Jarosinski K W, Tischer B K, Trapp S, Osterrieder N. 2006. Marek’s disease virus,  lytic replication, oncogenesis and control. Expert Review of Vaccines, 5, 761–772.

Johnson C L, Gale M Jr. 2006. CARD games between virus and host get a new player. Trends in Immunology, 27, 1–4.

Katze M G, He Y, Gale M Jr. 2002. Viruses and interferon,  a fight for supremacy. Nature Reviews Immunology, 2, 675–687.

Levy A M, Gilad O, Xia L, Izumiya Y, Choi J, Tsalenko A, Yakhini Z, Witter R, Lee L, Cardona C J, Kung H J. 2005. Marek’s disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade,  a converging transforming pathway for avian oncoviruses. Proceedings of the National Academy of Sciences of the United States of America, 102, 14831–14836.

Li K, Liu Y, Xu Z, Zhang Y, Luo D, Gao Y, Qian Y, Bao C, Liu C, Zhang Y, Qi X, Cui H, Wang Y, Gao L, Wang X. 2019. Avian oncogenic herpesvirus antagonizes the cGAS-STING DNA-sensing pathway to mediate immune evasion. PLoS Pathogens, 15, e1007999.

Lin R J, Liao C L, Lin E, Lin Y L. 2004. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. Journal of Virology, 78, 9285–9294.

Liu J L, Kung H J. 2000. Marek’s disease herpesvirus transforming protein Meq,  a c-Jun analogue with an alternative life style. Virus Genes, 21, 51–64.

Liu J L, Lin SF, Xia L, Brunovskis P, Li D, Davidson I, Lee L F, Kung H J. 1999. Meq and V-IL8,  cellular genes in disguise? Acta Virologica, 43, 94–101.

Miller D M, Rahill B M, Boss J M, Lairmore M D, Durbin J E, Waldman J W, Sedmak D D. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. Journal of Experimental Medicine, 187, 675–683.

Miller D M, Zhang Y, Rahill B M, Waldman W J, Sedmak D D. 1999. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. Journal of Immunology, 162, 6107–6113.

Ministry of Science and Technology of China. 2017. Guide for the care and use of laboratory animals of the Ministry of Science and Technology of China, 3rd ed. Central People’s Government of the People’s Republic of China, Beijing.

Morrow C, Fehler F. 2004. Marek’s disease: a worldwide problem. In: Davison F, Nair V (ed), Marek’s Disease,  An Evolving Problem. Elsevier, Amsterdam, The Netherlands.

Platanias L C. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nature Reviews Immunology, 5, 375–386.

Qian Z, Brunovskis P, Lee L, Vogt P K, Kung H J. 1996. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. Journal of Virology, 70, 7161–7170.

Qian Z, Brunovskis P, Rauscher F, Lee L, Kung H J. 1995. Transactivation activity of Meq, a Marek’s disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells. Journal of Virology, 69, 4037–4044.

Reid S P, Leung L W, Hartman A L, Martinez O, Shaw M L, Carbonnelle C, Volchkov V E, Nichol S T, Basler C F. 2006. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. Journal of Virology, 80, 5156-5167.

Ross N L. 1999. T-cell transformation by Marek’s disease virus. Trends in Microbiology, 7, 22–29.

Sun G R, Zhang Y P, Zhou L Y, Lv H C, Zhang F, Li K, Gao Y L, Qi X L, Cui H Y, Wang Y Q, Gao L, Pan Q, Wang X M, Liu C J. 2017. Co-Infection with Marek's Disease Virus and Reticuloendotheliosis Virus Increases Illness Severity and Reduces Marek's Disease Vaccine Efficacy. Viruses, 9, 158.

Sun M, Lin Q, Wang C, Xing J, Yan K, Liu Z, Jin Y, Cardona CJ, Xing Z. 2021. Enterovirus A71 2B inhibits interferon-activated JAK/STAT signaling by inducing caspase-3-dependent karyopherin-α1 degradation. Frontiers in Microbiology, 12, 762869.

Wang C, Sun M, Yuan X, Ji L, Jin Y, Cardona CJ, Xing Z. 2017. Enterovirus 71 suppresses interferon responses by blocking Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling through inducing karyopherin-α1 degradation. Journal of Biological Chemistry, 292, 10262–10274.

Weber F, Kochs G, Haller O. 2004. Inverse interference: how viruses fight the interferon system. Viral Immunology, 17, 498–515.

Wu J, Chen Z J. 2014. Innate immune sensing and signaling of cytosolic nucleic acids. Annual Review of Immunology, 32, 461–488.

Yokota S, Yokosawa N, Kubota T, Suzutani T, Yoshida I, Miura S, Jimbow K, Fujii N. 2001. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and Janus kinases during an early infection stage. Virology, 286, 119–124.